Gleason Group
BMY icon

Gleason Group’s Bristol-Myers Squibb BMY Stock Holding History

Gleason Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.3K Hold
101
– – ﹤0.01% 272
2026
Q2 		$5.82K Sell
101
-99
-50% -$5.68K ﹤0.01% 302
2026
Q1 		$12.1K Buy
+200
New +$11.7K ﹤0.01% 170
2024
Q3 		– Sell
-171
Closed -$7.1K – 201
2024
Q2 		$7.1K Buy
+171
New +$7.65K ﹤0.01% 206

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gleason Group's BMY Position: Q3 2026 in Review

Gleason Group held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 101 shares worth $6.3K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Gleason Group first reported a position in BMY in Q2 2024 and has held it in 4 quarters since. The position peaked at $12.1K in Q1 2026. 762 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Gleason Group held 101 shares of Bristol-Myers Squibb worth $6.3K as of Q3 2026.
  • Gleason Group left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Gleason Group's portfolio in Q3 2026, its #272 holding.
  • Gleason Group first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 4 quarters since.
  • Gleason Group's Bristol-Myers Squibb position peaked at $12.1K in Q1 2026.
  • 762 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Gleason Group's 13F filing for Q3 2026, filed 15 Oct 2026.